Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Children Cancer, Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00900354
What this trial is testing

Pharmacokinetics of Dactinomycin in Young Patients With Cancer

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group 50
Not applicableUnknownNCT02400970
What this trial is testing

Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors

Who this might be right for
Minimal Residual DiseaseFertility Preservation
University Hospital, Clermont-Ferrand 40
Not applicableStudy completedNCT00005881
What this trial is testing

Quality of Life in Children Treated for Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 538
Not applicableStudy completedNCT04471961
What this trial is testing

Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia

Who this might be right for
Pediatric TumorFamilial CancerSolid Tumor, Childhood+1 more
University Hospital, Montpellier 100
Early research (Phase 1)Looking for participantsNCT06865664
What this trial is testing

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00985868
What this trial is testing

AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Cancer Research UK 33
Not applicableLooking for participantsNCT06342453
What this trial is testing

CREATE: Art for Children With Cancer

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
OHSU Knight Cancer Institute 72
Early research (Phase 1)Looking for participantsNCT04308330
What this trial is testing

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Who this might be right for
Ewing SarcomaRhabdomyosarcomaWilms Tumor+3 more
New York Medical College 30
Not applicableStudy completedNCT00923468
What this trial is testing

Pharmacokinetic Studies Participation Survey

Who this might be right for
Relapsed Solid TumorsRelapsed LeukemiaRelapsed Brain Tumors
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00387920
What this trial is testing

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Central Nervous System MetastasesChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+7 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT02677116
What this trial is testing

Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Ended earlyNCT00428272
What this trial is testing

HGS-ETR2 to Treat Children With Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaNeuroblastoma+1 more
National Cancer Institute (NCI) 30
Not applicableNot Yet RecruitingNCT06873672
What this trial is testing

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Who this might be right for
Quality of Life (QOL)Patient-Reported Outcome Measures (PROMs)Pneumonia Childhood+3 more
RenJi Hospital 360
Early research (Phase 1)Study completedNCT01725191
What this trial is testing

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Childhood Solid Neoplasm
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)UnknownNCT00751894
What this trial is testing

Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)

Who this might be right for
Solid Malignancies
University Hospital, Clermont-Ferrand 30
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Testing effectiveness (Phase 2)Ended earlyNCT00949117
What this trial is testing

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

Who this might be right for
LeukemiaLymphomaMalnutrition+3 more
University of South Florida 9
Early research (Phase 1)Study completedNCT03611595
What this trial is testing

Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

Who this might be right for
Solid Tumor
Peter Zage 15
Testing effectiveness (Phase 2)Study completedNCT03245450
What this trial is testing

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

Who this might be right for
Refractory or Recurrent Solid TumorsRhabdomyosarcomaNon-Rhabdomyosarcoma Soft Tissue Sarcoma+1 more
Eisai Inc. 40
Next Page